Copyright Reports & Markets. All rights reserved.

Global Chemotherapy-induced Nausea and Vomiting Drugs Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Chemotherapy-induced Nausea and Vomiting Drugs Market Overview

      • 1.1 Product Overview and Scope of Chemotherapy-induced Nausea and Vomiting Drugs
      • 1.2 Chemotherapy-induced Nausea and Vomiting Drugs Segment by Type
        • 1.2.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 5-HT3 Inhibitors
        • 1.2.3 NK1 Inhibitors
        • 1.2.4 Other
      • 1.3 Chemotherapy-induced Nausea and Vomiting Drugs Segment by Application
        • 1.3.1 Chemotherapy-induced Nausea and Vomiting Drugs Consumption Comparison by Application (2014-2025)
        • 1.3.2 Highly Emetogenic Chemotherapy
        • 1.3.3 Moderately Emetogenic Chemotherapy
        • 1.3.4 Low Emetogenic Chemotherapy
        • 1.3.5 Other
      • 1.4 Global Chemotherapy-induced Nausea and Vomiting Drugs Market by Region
        • 1.4.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Market Size Region
        • 1.4.2 North America Status and Prospect (2014-2025)
        • 1.4.3 Europe Status and Prospect (2014-2025)
        • 1.4.4 China Status and Prospect (2014-2025)
        • 1.4.5 Japan Status and Prospect (2014-2025)
      • 1.5 Global Chemotherapy-induced Nausea and Vomiting Drugs Market Size
        • 1.5.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue (2014-2025)
        • 1.5.2 Global Chemotherapy-induced Nausea and Vomiting Drugs Production (2014-2025)

      2 Global Chemotherapy-induced Nausea and Vomiting Drugs Market Competition by Manufacturers

      • 2.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Chemotherapy-induced Nausea and Vomiting Drugs Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Chemotherapy-induced Nausea and Vomiting Drugs Production Sites, Area Served, Product Types
      • 2.5 Chemotherapy-induced Nausea and Vomiting Drugs Market Competitive Situation and Trends
        • 2.5.1 Chemotherapy-induced Nausea and Vomiting Drugs Market Concentration Rate
        • 2.5.2 Chemotherapy-induced Nausea and Vomiting Drugs Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Chemotherapy-induced Nausea and Vomiting Drugs Production Market Share by Regions

      • 3.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Production Market Share by Regions
      • 3.2 Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Chemotherapy-induced Nausea and Vomiting Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Chemotherapy-induced Nausea and Vomiting Drugs Production
        • 3.4.1 North America Chemotherapy-induced Nausea and Vomiting Drugs Production Growth Rate (2014-2019)
        • 3.4.2 North America Chemotherapy-induced Nausea and Vomiting Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Chemotherapy-induced Nausea and Vomiting Drugs Production
        • 3.5.1 Europe Chemotherapy-induced Nausea and Vomiting Drugs Production Growth Rate (2014-2019)
        • 3.5.2 Europe Chemotherapy-induced Nausea and Vomiting Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Chemotherapy-induced Nausea and Vomiting Drugs Production (2014-2019)
        • 3.6.1 China Chemotherapy-induced Nausea and Vomiting Drugs Production Growth Rate (2014-2019)
        • 3.6.2 China Chemotherapy-induced Nausea and Vomiting Drugs Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Chemotherapy-induced Nausea and Vomiting Drugs Production (2014-2019)
        • 3.7.1 Japan Chemotherapy-induced Nausea and Vomiting Drugs Production Growth Rate (2014-2019)
        • 3.7.2 Japan Chemotherapy-induced Nausea and Vomiting Drugs Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Chemotherapy-induced Nausea and Vomiting Drugs Consumption by Regions

      • 4.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Consumption by Regions
      • 4.2 North America Chemotherapy-induced Nausea and Vomiting Drugs Consumption (2014-2019)
      • 4.3 Europe Chemotherapy-induced Nausea and Vomiting Drugs Consumption (2014-2019)
      • 4.4 China Chemotherapy-induced Nausea and Vomiting Drugs Consumption (2014-2019)
      • 4.5 Japan Chemotherapy-induced Nausea and Vomiting Drugs Consumption (2014-2019)

      5 Global Chemotherapy-induced Nausea and Vomiting Drugs Production, Revenue, Price Trend by Type

      • 5.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Production Market Share by Type (2014-2019)
      • 5.2 Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share by Type (2014-2019)
      • 5.3 Global Chemotherapy-induced Nausea and Vomiting Drugs Price by Type (2014-2019)
      • 5.4 Global Chemotherapy-induced Nausea and Vomiting Drugs Production Growth by Type (2014-2019)

      6 Global Chemotherapy-induced Nausea and Vomiting Drugs Market Analysis by Applications

      • 6.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Consumption Market Share by Application (2014-2019)
      • 6.2 Global Chemotherapy-induced Nausea and Vomiting Drugs Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Chemotherapy-induced Nausea and Vomiting Drugs Business

      • 7.1 Merck
        • 7.1.1 Merck Chemotherapy-induced Nausea and Vomiting Drugs Production Sites and Area Served
        • 7.1.2 Chemotherapy-induced Nausea and Vomiting Drugs Product Introduction, Application and Specification
        • 7.1.3 Merck Chemotherapy-induced Nausea and Vomiting Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Eisai
        • 7.2.1 Eisai Chemotherapy-induced Nausea and Vomiting Drugs Production Sites and Area Served
        • 7.2.2 Chemotherapy-induced Nausea and Vomiting Drugs Product Introduction, Application and Specification
        • 7.2.3 Eisai Chemotherapy-induced Nausea and Vomiting Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Mundipharma
        • 7.3.1 Mundipharma Chemotherapy-induced Nausea and Vomiting Drugs Production Sites and Area Served
        • 7.3.2 Chemotherapy-induced Nausea and Vomiting Drugs Product Introduction, Application and Specification
        • 7.3.3 Mundipharma Chemotherapy-induced Nausea and Vomiting Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Qilu Pharma
        • 7.4.1 Qilu Pharma Chemotherapy-induced Nausea and Vomiting Drugs Production Sites and Area Served
        • 7.4.2 Chemotherapy-induced Nausea and Vomiting Drugs Product Introduction, Application and Specification
        • 7.4.3 Qilu Pharma Chemotherapy-induced Nausea and Vomiting Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Teva
        • 7.5.1 Teva Chemotherapy-induced Nausea and Vomiting Drugs Production Sites and Area Served
        • 7.5.2 Chemotherapy-induced Nausea and Vomiting Drugs Product Introduction, Application and Specification
        • 7.5.3 Teva Chemotherapy-induced Nausea and Vomiting Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Novartis
        • 7.6.1 Novartis Chemotherapy-induced Nausea and Vomiting Drugs Production Sites and Area Served
        • 7.6.2 Chemotherapy-induced Nausea and Vomiting Drugs Product Introduction, Application and Specification
        • 7.6.3 Novartis Chemotherapy-induced Nausea and Vomiting Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 Heron Therapeutics
        • 7.7.1 Heron Therapeutics Chemotherapy-induced Nausea and Vomiting Drugs Production Sites and Area Served
        • 7.7.2 Chemotherapy-induced Nausea and Vomiting Drugs Product Introduction, Application and Specification
        • 7.7.3 Heron Therapeutics Chemotherapy-induced Nausea and Vomiting Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Roche
        • 7.8.1 Roche Chemotherapy-induced Nausea and Vomiting Drugs Production Sites and Area Served
        • 7.8.2 Chemotherapy-induced Nausea and Vomiting Drugs Product Introduction, Application and Specification
        • 7.8.3 Roche Chemotherapy-induced Nausea and Vomiting Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 Mylan
        • 7.9.1 Mylan Chemotherapy-induced Nausea and Vomiting Drugs Production Sites and Area Served
        • 7.9.2 Chemotherapy-induced Nausea and Vomiting Drugs Product Introduction, Application and Specification
        • 7.9.3 Mylan Chemotherapy-induced Nausea and Vomiting Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served
      • 7.10 Tesaro
        • 7.10.1 Tesaro Chemotherapy-induced Nausea and Vomiting Drugs Production Sites and Area Served
        • 7.10.2 Chemotherapy-induced Nausea and Vomiting Drugs Product Introduction, Application and Specification
        • 7.10.3 Tesaro Chemotherapy-induced Nausea and Vomiting Drugs Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.10.4 Main Business and Markets Served

      8 Chemotherapy-induced Nausea and Vomiting Drugs Manufacturing Cost Analysis

      • 8.1 Chemotherapy-induced Nausea and Vomiting Drugs Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Chemotherapy-induced Nausea and Vomiting Drugs
      • 8.4 Chemotherapy-induced Nausea and Vomiting Drugs Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Chemotherapy-induced Nausea and Vomiting Drugs Distributors List
      • 9.3 Chemotherapy-induced Nausea and Vomiting Drugs Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Chemotherapy-induced Nausea and Vomiting Drugs Market Forecast

      • 11.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Production, Revenue Forecast
        • 11.1.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Chemotherapy-induced Nausea and Vomiting Drugs Price and Trend Forecast (2019-2025)
      • 11.2 Global Chemotherapy-induced Nausea and Vomiting Drugs Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Chemotherapy-induced Nausea and Vomiting Drugs Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Chemotherapy-induced Nausea and Vomiting Drugs Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Chemotherapy-induced Nausea and Vomiting Drugs Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Chemotherapy-induced Nausea and Vomiting Drugs Production, Revenue Forecast (2019-2025)
      • 11.3 Global Chemotherapy-induced Nausea and Vomiting Drugs Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Chemotherapy-induced Nausea and Vomiting Drugs Consumption Forecast (2019-2025)
        • 11.3.2 Europe Chemotherapy-induced Nausea and Vomiting Drugs Consumption Forecast (2019-2025)
        • 11.3.3 China Chemotherapy-induced Nausea and Vomiting Drugs Consumption Forecast (2019-2025)
        • 11.3.4 Japan Chemotherapy-induced Nausea and Vomiting Drugs Consumption Forecast (2019-2025)
      • 11.4 Global Chemotherapy-induced Nausea and Vomiting Drugs Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Chemotherapy-induced Nausea and Vomiting Drugs Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Chemotherapy induced nausea and vomiting (CINV) drugs refer to medication or treatment that is offered to cancer patients who experience nausea and vomiting due to chemotherapy.
        The classification of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs includes 5-HT3 Inhibitors, NK1 Inhibitors and others. The proportion of 5-HT3 Inhibitors in 2017 is about 62%, and the proportion of NK1 Inhibitors in 2017 is about 33%.
        Chemotherapy Induced Nausea and Vomiting (CINV) Drugs are application for Highly Emetogenic Chemotherapy, Moderately Emetogenic Chemotherapy, Low Emetogenic Chemotherapy and others. The most of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs is used for Moderately Emetogenic Chemotherapy, and the market share of that is about 52 % in 2017.
        North America is the largest consumption place, with a consumption market share nearly 51% in 2017; Europe is the second largest consumption place with the consumption market share of 21% in 2017.
        Market competition is not intense. Merck, Eisai, Mundipharma, Qilu Pharma, Teva, Novartis etc. are the leaders of the industry with the market share are about 66% in 2017.

        The global Chemotherapy-induced Nausea and Vomiting Drugs market is valued at 1740 million US$ in 2018 is expected to reach 2460 million US$ by the end of 2025, growing at a CAGR of 4.4% during 2019-2025.
        This report focuses on Chemotherapy-induced Nausea and Vomiting Drugs volume and value at global level, regional level and company level. From a global perspective, this report represents overall Chemotherapy-induced Nausea and Vomiting Drugs market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        Merck
        Eisai
        Mundipharma
        Qilu Pharma
        Teva
        Novartis
        Heron Therapeutics
        Roche
        Mylan
        Tesaro

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        5-HT3 Inhibitors
        NK1 Inhibitors
        Other

        Segment by Application
        Highly Emetogenic Chemotherapy
        Moderately Emetogenic Chemotherapy
        Low Emetogenic Chemotherapy
        Other

        Buy now